Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Total Liabilities (2016 - 2025)

Historic Total Liabilities for HUTCHMED (China) (HCM) over the last 12 years, with Q2 2025 value amounting to $534.0 million.

  • HUTCHMED (China)'s Total Liabilities rose 494.59% to $534.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $534.0 million, marking a year-over-year increase of 494.59%. This contributed to the annual value of $64.4 billion for FY2024, which is 9378515262.15% up from last year.
  • Per HUTCHMED (China)'s latest filing, its Total Liabilities stood at $534.0 million for Q2 2025, which was up 494.59% from $64.6 billion recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Total Liabilities registered a high of $64.6 billion during Q4 2024, and its lowest value of $68647.0 during Q4 2023.
  • In the last 5 years, HUTCHMED (China)'s Total Liabilities had a median value of $303.3 million in 2021 and averaged $6.7 billion.
  • As far as peak fluctuations go, HUTCHMED (China)'s Total Liabilities tumbled by 9986.32% in 2023, and later soared by 9412913351.39% in 2024.
  • Over the past 5 years, HUTCHMED (China)'s Total Liabilities (Quarter) stood at $264.2 million in 2021, then plummeted by 81.0% to $50.2 million in 2022, then tumbled by 99.86% to $68647.0 in 2023, then soared by 94129133.51% to $64.6 billion in 2024, then crashed by 99.17% to $534.0 million in 2025.
  • Its Total Liabilities was $534.0 million in Q2 2025, compared to $64.6 billion in Q4 2024 and $508.8 million in Q2 2024.